Twelve of the 26 NVAMD patients (46.1%) had active choroidal neovascularization at the time of the blood draw, and 9 (34.6%) patients had received an intravitreal injection of anti-vascular endothelial growth factor (VEGF) within the preceding two months. This evidence concerns the gene VEGFA and choroidal neovascularization.